The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
Takenobu Katagiri(Saitama Medical University), Tatsuo Suda(SHOWA Medical University), Satoshi Ōmura(Kitasato Institute Hospital), Haruo Tanaka(Showa University), Tohru Ikeda(Tokyo Medical and Dental University), Elizabeth A. Wang, John M. Wozney, Akira Yamaguchi(The University of Melbourne), Vicki Rosen(Harvard University), Shusaku Yoshiki(Showa University)
Cited by 497
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
|Journal of Bone and Mineral Research|1996|548